Trial Profile
A Randomized Study of a Rapid HCV Treatment Initiation Strategy (HCV Seek, Test and Rapid Treatment) Compared to Standard Care in Young People Who Inject Drugs
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Jul 2021
Price :
$35
*
At a glance
- Drugs Sofosbuvir/velpatasvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- Acronyms HCV ST&RT
- 27 Jul 2021 Status changed from recruiting to completed.
- 09 Nov 2020 Planned End Date changed from 10 Jul 2021 to 10 Jul 2022.
- 09 Nov 2020 Planned primary completion date changed from 10 Jul 2021 to 10 Jul 2022.